Share Email Print
cover

Proceedings Paper

Hybridization-triggered fluorescence detection of DNA with minor groove binder-conjugated probes
Author(s): Irina A. Afonina; Sergey G. Lokhov; Yevheniy S. Belousov; Michael W. Reed; Eugeny A. Lukhtanov; Irina G. Shishkina; Vladimir V. Gorn; Silvia M. Sanders; David K. Walburger; Merl F. Hoekstra; Nicolaas M. J. Vermeulen
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

Fluorogenic 2'-deoxynucleotide probes containing a minor groove binding-quencher compound at the 5'-end and a fluorophore at the 3'-end, were recently described. These probes fluoresce upon hybridization to the complementary target. The 5'-MGB-quencher group prevents 5'-nuclease digestion by Taq polymerase during homogeneous amplification. The 5'-MGB-quencher-oligonucleotide-fluor (MGB-Q-ODN-Fl) probes displayed a dynamic range of 7 order of magnitude, with an ultimate sensitivity of better than 5 copies per sample. The high sensitivity and specificity is illustrated by the application of the probes in single nucleotide polymorphism detection, final load determination and gene expression analyses. This paper summarizes new developments in sequence detection, gene expression and SNP analysis using new Tm prediction software to design robust 5'-MGB-Q-ODN-Fl probes. Furthermore, the software is capable of estimating the Tm of probes containing a modified base. Due to G:G self-association, many G-rich probes and primers are poor performers in amplification reactions. The software recognizes such sequences and substitution of G with 6-Amino-1,5-dihydro-pyrazolo(3,4- d)pyrimidin-4-one (PPG) is indicated, when necessary to eliminate G:G self-association. Examples of improved performance of PPG containing primers and probes is demonstrated.

Paper Details

Date Published: 21 June 2002
PDF: 10 pages
Proc. SPIE 4626, Biomedical Nanotechnology Architectures and Applications, (21 June 2002); doi: 10.1117/12.472099
Show Author Affiliations
Irina A. Afonina, Epoch Biosciences, Inc. (United States)
Sergey G. Lokhov, Epoch Biosciences, Inc. (United States)
Yevheniy S. Belousov, Epoch Biosciences, Inc. (United States)
Michael W. Reed, Epoch Biosciences, Inc. (United States)
Eugeny A. Lukhtanov, Epoch Biosciences, Inc. (United States)
Irina G. Shishkina, Epoch Biosciences, Inc. (United States)
Vladimir V. Gorn, Epoch Biosciences, Inc. (United States)
Silvia M. Sanders, Epoch Biosciences, Inc. (United States)
David K. Walburger, Epoch Biosciences, Inc. (United States)
Merl F. Hoekstra, Epoch Biosciences, Inc. (United States)
Nicolaas M. J. Vermeulen, Epoch Biosciences, Inc. (United States)


Published in SPIE Proceedings Vol. 4626:
Biomedical Nanotechnology Architectures and Applications
Raymond P. Mariella; Catherine J. Murphy; Michelle Palmer; David A. Dunn; Darryl J. Bornhop; David A. Dunn; Raymond P. Mariella; Catherine J. Murphy; Dan V. Nicolau; Shuming Nie; Michelle Palmer; Ramesh Raghavachari; Darryl J. Bornhop; Ramesh Raghavachari; Shuming Nie; Ramesh Raghavachari, Editor(s)

© SPIE. Terms of Use
Back to Top